Source disclosure: February 19, 2026
Carna Biosciences,Inc. [4572.T]
TOKYO, Feb 19 (Pulse News Wire) -- Carna Biosciences, Inc. (4572.T), represented by President and CEO Yoshino Koichiro, announced today that its board of directors has resolved to propose amendments to the company's articles of incorporation at its upcoming 23rd Annual General Meeting scheduled for March 25, 2026. The proposed changes aim to increase the total number of shares the company is authorized to issue, thereby enhancing its flexibility in capital policy moving forward.
The current situation necessitates this change as Carna Biosciences' total outstanding share count stood at 19,196,700 shares on February 17, 2026, while the number of potential shares was 10,290,683. This means that the sum of outstanding and potential shares is approaching the maximum allowable issuance limit of 30 million shares, leaving very little room for new issuances. To address this constraint and ensure greater maneuverability in future capital strategies, the company plans to raise its authorized share issuance cap.
Under the proposed amendment, Article 6 of the company’s articles of incorporation will be changed from stating “the total number of shares the company may issue shall be 30,000,000” to “the total number of shares the company may issue shall be 76,000,000.” If approved, these changes would take effect immediately upon adoption at the annual general meeting on March 25, 2026.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing